Le SIBUTRAL® est le nom de marque en France de la sibutramine,
commercialisée dans d'autres pays sous le nom de REDUCTIL® ou de MERIDIA®. Il s'agit d'un
anorexigène sérotoninergique et noradrénergique. Sibutral Réductil et
Meridia sont
des marques déposées propriété des laboratoires
Knoll
Randomized, double-blind, placebo-controlled, multicenter
study of sibutramine in obese hypertensive patients.
Cardiology. 2000;94(3):152-8.
PMID: 11279320 [PubMed - indexed for MEDLINE]
[Ten questions on the treatment of obesity: from dieting to
surgery].
Rev Med Suisse Romande. 2001 Jan;121(1):57-63.
Review. French.
PMID: 11234711 [PubMed - indexed for MEDLINE]
Weight loss with sibutramine improves glycaemic control and
other metabolic parameters in obese patients with type 2
diabetes mellitus.
Diabetes Obes Metab. 2000 Jun;2(3):175-87.
PMID: 11220553 [PubMed - indexed for MEDLINE]
Sibutramine is effective for weight loss and diabetic control
in obesity with type 2 diabetes: a randomised, double-blind,
placebo-controlled study.
Diabetes Obes Metab. 2000 Apr;2(2):105-12.
PMID: 11220522 [PubMed - indexed for MEDLINE]
[Evolution and weight and body composition determination after
therapy for pathological obesity for measuring compliance in
(re)-education].
Bull Soc Sci Med Grand Duche Luxemb.
2000;(1):17-29. French.
PMID: 11200309 [PubMed - indexed for MEDLINE]
Effect of sibutramine on weight maintenance after weight loss:
a randomised trial. STORM Study Group. Sibutramine Trial of
Obesity Reduction and Maintenance.
Lancet. 2000 Dec 23-30;356(9248):2119-25.
PMID: 11191537 [PubMed - indexed for MEDLINE]
Use of sibutramine and other noradrenergic and serotonergic
drugs in the management of obesity.
Endocrine. 2000 Oct;13(2):193-9. Review.
PMID: 11186220 [PubMed - indexed for MEDLINE]
Benefits of lifestyle modification in the pharmacologic
treatment of obesity: a randomized trial.
Arch Intern Med. 2001 Jan 22;161(2):218-27.
PMID: 11176735 [PubMed - indexed for MEDLINE]
Effects of sibutramine plus orlistat in obese women following
1 year of treatment by sibutramine alone: a placebo-controlled
trial.
Obes Res. 2000 Sep;8(6):431-7.
PMID: 11011909 [PubMed - indexed for MEDLINE]
[The obesity epidemics--do diet pills have a place in the
treatment]?
Tidsskr Nor Laegeforen. 2000 Jun
30;120(17):1997-2001. Review. Norwegian.
PMID: 11008533 [PubMed - indexed for MEDLINE]
Drug treatment of obesity.
Baillieres Best Pract Res Clin Endocrinol Metab.
1999 Apr;13(1):131-48. Review.
PMID: 10932681 [PubMed - indexed for MEDLINE]
Managing obesity like any other chronic condition. Long-term
therapy may reduce comorbidity as well.
Postgrad Med. 2000 Jul;108(1):75-6, 79-82.
Review.
PMID: 10914120 [PubMed - indexed for MEDLINE]
Efficacy and safety of sibutramine in obese white and African
American patients with hypertension: a 1-year, double-blind,
placebo-controlled, multicenter trial.
Arch Intern Med. 2000 Jul 24;160(14):2185-91.
PMID: 10904462 [PubMed - indexed for MEDLINE]
Change in intra-abdominal adipose tissue volume during weight
loss in obese men and women: correlation between magnetic
resonance imaging and anthropometric measurements.
Int J Obes Relat Metab Disord. 2000
May;24(5):607-13.
PMID: 10849583 [PubMed - indexed for MEDLINE]
The effects of drugs used to treat obesity on the autonomic
nervous system.
Obes Res. 2000 May;8(3):227-33.
PMID: 10832765 [PubMed - indexed for MEDLINE]
[Drug therapy of obesity. Strategies for general practice].
Schweiz Rundsch Med Prax. 2000 Mar
30;89(14):575-85. Review. German.
PMID: 10815465 [PubMed - indexed for MEDLINE]
Antiobesity pharmacotherapy in the management of type 2
diabetes.
Diabetes Metab Res Rev. 2000 Mar-Apr;16(2):114-24.
Review.
PMID: 10751751 [PubMed - indexed for MEDLINE]
[How safe are the new obesity drugs? Indications and
contraindications of orlistat and sibutramine].
MMW Fortschr Med. 1999 Dec 9;141(49-50):32-6.
German.
PMID: 10726144 [PubMed - indexed for MEDLINE]
Modalities of the food intake-reducing effect of sibutramine
in humans.
Physiol Behav. 2000 Jan;68(3):299-308.
PMID: 10716539 [PubMed - indexed for MEDLINE]
Six-month treatment of obesity with sibutramine 15 mg; a
double-blind, placebo-controlled monocenter clinical trial in a
Hispanic population.
Obes Res. 2000 Jan;8(1):71-82.
PMID: 10678261 [PubMed - indexed for MEDLINE]
A clinical trial of the use of sibutramine for the treatment
of patients suffering essential obesity.
Int J Obes Relat Metab Disord. 2000 Feb;24(2):144-50.
PMID: 10702763 [PubMed - indexed for MEDLINE]
Effects of sibutramine alone and with alcohol on cognitive
function in healthy volunteers.
Br J Clin Pharmacol. 2000 Feb;49(2):110-7.
PMID: 10671904 [PubMed - indexed for MEDLINE]
Sibutramine and thermogenesis in humans.
Int J Obes Relat Metab Disord. 1999 Oct;23(10):1007-8.
Review. No abstract available.
PMID: 10557019 [PubMed - indexed for MEDLINE]
The effect of sibutramine on energy expenditure and appetite
during chronic treatment without dietary restriction.
Int J Obes Relat Metab Disord. 1999 Oct;23(10):1016-24.
PMID: 10557021 [PubMed - indexed for MEDLINE]
The effect of sibutramine on resting energy expenditure and
adrenaline-induced thermogenesis in obese females.
Int J Obes Relat Metab Disord. 1999 Oct;23(10):1009-15.
PMID: 10557020 [PubMed - indexed for MEDLINE]
Sibutramine: a serotonin-norepinephrine reuptake-inhibitor for
the treatment of obesity.
Ann Pharmacother. 1999 Sep;33(9):968-78. Review.
PMID: 10492502 [PubMed - indexed for MEDLINE]
The impact of pharmacotherapy on weight management in type 2
diabetes.
Int J Obes Relat Metab Disord. 1999 Jun;23 Suppl
7:S12-7. Review.
PMID: 10455466 [PubMed - indexed for MEDLINE]
Obesity and type 2 diabetes: a conflict of interests?
Int J Obes Relat Metab Disord. 1999 Jun;23 Suppl
7:S2-4. Review.
PMID: 10455464 [PubMed - indexed for MEDLINE]
Long-term maintenance of weight loss after a very-low-calorie
diet: a randomized blinded trial of the efficacy and
tolerability of sibutramine.
Am J Med. 1999 Feb;106(2):179-84.
PMID: 10230747 [PubMed - indexed for MEDLINE]
[What is the role of drugs in therapy of obesity]?
Wien Med Wochenschr. 1998;148(17):401-2. Review.
German.
PMID: 9887502 [PubMed - indexed for MEDLINE]
[Sibutramine, an upcoming drug for weight loss acting on
energy consumption and energy expenditure].
Acta Med Austriaca. 1998;25(4-5):146-9. Review.
German.
PMID: 9879391 [PubMed - indexed for MEDLINE]
Sibutramine. A review of its contribution to the management of
obesity.
Drugs. 1998 Dec;56(6):1093-124. Review.
PMID: 9878996 [PubMed - indexed for MEDLINE]
Anti-obesity drugs: what does sibutramine offer? An analysis
of its potential contribution to obesity treatment.
Exp Clin Endocrinol Diabetes. 1998;106 Suppl
2:35-40. Review.
PMID: 9792480 [PubMed - indexed for MEDLINE]
Modern medical management of obesity: the role of
pharmaceutical intervention.
J Am Diet Assoc. 1998 Oct;98(10 Suppl 2):S23-6.
Review.
PMID: 9787732 [PubMed - indexed for MEDLINE]
Sibutramine (Meridia)--dental considerations for a new weight
control drug.
Gen Dent. 1998 Jul-Aug;46(4):332-5. Review. No
abstract available.
PMID: 9758977 [PubMed - indexed for MEDLINE]
Sibutramine and fat distribution: is there a role for
pharmacotherapy in abdominal/visceral fat reduction?
Int J Obes Relat Metab Disord. 1998 Aug;22 Suppl
1:S38-40; discussion S41-2.
PMID: 9758242 [PubMed - indexed for MEDLINE]
Sibutramine: a novel anti-obesity drug. A review of the
pharmacological evidence to differentiate it from d-amphetamine
and d-fenfluramine.
Int J Obes Relat Metab Disord. 1998 Aug;22 Suppl
1:S18-28; discussion S29. Review.
PMID: 9758240 [PubMed - indexed for MEDLINE]
The cost implications of obesity for health care and society.
Int J Obes Relat Metab Disord. 1998 Aug;22 Suppl
1:S3-5; discussion S6. Review.
PMID: 9758237 [PubMed - indexed for MEDLINE]
A comparison of sibutramine and dexfenfluramine in the
treatment of obesity.
Obes Res. 1998 Jul;6(4):285-91.
PMID: 9688105 [PubMed - indexed for MEDLINE]
Sibutramine: a new weight loss agent without evidence of the
abuse potential associated with amphetamines.
J Clin Psychopharmacol. 1998 Jun;18(3):231-6.
PMID: 9617982 [PubMed - indexed for MEDLINE]
Effects of sibutramine on resting metabolic rate and weight
loss in overweight women.
Obes Res. 1998 Mar;6(2):115-21.
PMID: 9545017 [PubMed - indexed for MEDLINE]
Efficacy and tolerability of sibutramine in obese patients: a
dose-ranging study.
Int J Obes Relat Metab Disord. 1998
Jan;22(1):32-8.
PMID: 9481597 [PubMed - indexed for MEDLINE]
Sibutramine: a review of the pharmacology of a novel anti-obesity
agent.
Int J Obes Relat Metab Disord. 1997 Mar;21 Suppl
1:S25-9. Review.
PMID: 9130038 [PubMed - indexed for MEDLINE]
Dexfenfluramine. An updated review of its therapeutic use in
the management of obesity.
Drugs. 1996 Nov;52(5):696-724. Review.
PMID: 9118819 [PubMed - indexed for MEDLINE]
Stress: a major variable in the psychopharmacologic response.
Pharmacol Biochem Behav. 1996 May;54(1):211-7.
Review.
PMID: 8728560 [PubMed - indexed for MEDLINE]
